Dear Editor, Clinical exacerbations were found in the patient being monitored in the dermatology clinic, 3 days after the start of systemic sodium stibogluconate treatment for cutaneous leishmaniasis (CL). The patient was the 5-year-old daughter of the first patient, who also had facial CL lesion, and the clinical exacerbation was seen on the 3rd day of treatment (systemic sodium stibogluconate) ( Figure 1 ). This treatment was continued in both patients with the addition of 0.5 mg/kg prednisolone for 3 days. Rapid clinical recovery was shown in both patients with systemic corticosteroid (Figures 1d and 2d) .
Exacerbation of skin lesions during the treatment of bacterial, viral, fungal, and parasitic diseases is evaluated as an id reaction. This id reaction occurs as a result of the cellular reaction in response to the settlement of fragments resulting from fragmentation or toxins of the pathogen organism together with treatment (1). Particularly, in the id reaction created in tinea capitis profunda disease, the inflammatory reaction is known to be reduced with short-term corticosteroid treatment. With this treatment, an evident clinical recovery was shown in our CL patients. There are previous studies in literature related to the id reaction in CL disease (2-6).
In conclusion, the short-term systemic corticosteroid treatment of clinical exacerbation, which develops during treatment of CL disease, can be useful in achieving a rapid clinical recovery in the patient, increasing the success rate of the cure following treatment, and most importantly, minimizing the potential development of ugly scar tissue. In conclusion, the short-term systemic corticosteroid treatment of clinical exacerbation which develops during treatment of CL disease can be useful in achieving a rapid clinical recovery for the patient, in increasing the success rate of the cure following treatment and most importantly, in minimising the potential development of ugly scar tissue.
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